155 related articles for article (PubMed ID: 28598827)
1. Expression analysis of long non-coding ATB and its putative target in breast cancer.
Nikpayam E; Soudyab M; Tasharrofi B; Sarrafzadeh S; Iranpour M; Geranpayeh L; Mirfakhraie R; Gharesouran J; Ghafouri-Fard S
Breast Dis; 2017; 37(1):11-20. PubMed ID: 28598827
[TBL] [Abstract][Full Text] [Related]
2. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864
[TBL] [Abstract][Full Text] [Related]
3. LncRNA-ATB mediated E-cadherin repression promotes the progression of colon cancer and predicts poor prognosis.
Yue B; Qiu S; Zhao S; Liu C; Zhang D; Yu F; Peng Z; Yan D
J Gastroenterol Hepatol; 2016 Mar; 31(3):595-603. PubMed ID: 26487301
[TBL] [Abstract][Full Text] [Related]
4. LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer.
Shi SJ; Wang LJ; Yu B; Li YH; Jin Y; Bai XZ
Oncotarget; 2015 May; 6(13):11652-63. PubMed ID: 25871474
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of lncRNA-ATB correlates with clinical progression and unfavorable prognosis in pancreatic cancer.
Qu S; Yang X; Song W; Sun W; Li X; Wang J; Zhong Y; Shang R; Ruan B; Zhang Z; Zhang X; Li H
Tumour Biol; 2016 Mar; 37(3):3933-8. PubMed ID: 26482611
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma.
Xu S; Yi XM; Tang CP; Ge JP; Zhang ZY; Zhou WQ
Oncol Rep; 2016 Jul; 36(1):10-22. PubMed ID: 27176634
[TBL] [Abstract][Full Text] [Related]
7. A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma.
Yuan JH; Yang F; Wang F; Ma JZ; Guo YJ; Tao QF; Liu F; Pan W; Wang TT; Zhou CC; Wang SB; Wang YZ; Yang Y; Yang N; Zhou WP; Yang GS; Sun SH
Cancer Cell; 2014 May; 25(5):666-81. PubMed ID: 24768205
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of lncRNA-ATB inhibits epithelial-mesenchymal transition of breast cancer cells by increasing miR-141-3p expression.
Zhang Y; Li J; Jia S; Wang Y; Kang Y; Zhang W
Biochem Cell Biol; 2019 Apr; 97(2):193-200. PubMed ID: 30352165
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β: LncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia.
Richards EJ; Zhang G; Li ZP; Permuth-Wey J; Challa S; Li Y; Kong W; Dan S; Bui MM; Coppola D; Mao WM; Sellers TA; Cheng JQ
J Biol Chem; 2015 Mar; 290(11):6857-67. PubMed ID: 25605728
[TBL] [Abstract][Full Text] [Related]
10. A long noncoding RNA, lncRNA-ATB, is involved in the progression and prognosis of colorectal cancer.
Iguchi T; Uchi R; Nambara S; Saito T; Komatsu H; Hirata H; Ueda M; Sakimura S; Takano Y; Kurashige J; Shinden Y; Eguchi H; Sugimachi K; Maehara Y; Mimori K
Anticancer Res; 2015 Mar; 35(3):1385-8. PubMed ID: 25750289
[TBL] [Abstract][Full Text] [Related]
11. Assessment of expression of interferon γ (IFN-G) gene and its antisense (IFNG-AS1) in breast cancer.
Yaghoobi H; Azizi H; Oskooei VK; Taheri M; Ghafouri-Fard S
World J Surg Oncol; 2018 Oct; 16(1):211. PubMed ID: 30336781
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA activated by transforming growth factor-β promotes cancer development and is a prognostic marker in cervical cancer.
Cao W; Peng T; Zhou Y
J Cancer Res Ther; 2017; 13(5):801-806. PubMed ID: 29237907
[TBL] [Abstract][Full Text] [Related]
13. Expression analysis of selected miR-206 targets from the transforming growth factor-β signaling pathway in breast cancer.
Seifi-Alan M; Dianatpour A; Geranpayeh L; Mirfakhraie R; Omrani MD; Ghafouri-Fard S
J Cell Biochem; 2019 Aug; 120(8):13545-13553. PubMed ID: 30920079
[TBL] [Abstract][Full Text] [Related]
14. Serum LncRNA-ATB and FAM83H-AS1 as diagnostic/prognostic non-invasive biomarkers for breast cancer.
El-Ashmawy NE; Hussien FZ; El-Feky OA; Hamouda SM; Al-Ashmawy GM
Life Sci; 2020 Oct; 259():118193. PubMed ID: 32763293
[TBL] [Abstract][Full Text] [Related]
15. High expression of long non-coding RNA ATB indicates a poor prognosis and regulates cell proliferation and metastasis in non-small cell lung cancer.
Ke L; Xu SB; Wang J; Jiang XL; Xu MQ
Clin Transl Oncol; 2017 May; 19(5):599-605. PubMed ID: 27878433
[TBL] [Abstract][Full Text] [Related]
16. Role of LncRNA-activated by transforming growth factor beta in the progression of hepatitis C virus-related liver fibrosis.
Fu N; Niu X; Wang Y; Du H; Wang B; Du J; Li Y; Wang R; Zhang Y; Zhao S; Sun D; Qiao L; Nan Y
Discov Med; 2016 Aug; 22(119):29-42. PubMed ID: 27585228
[TBL] [Abstract][Full Text] [Related]
17. Expression analysis of AFAP1-AS1 and AFAP1 in breast cancer.
Dianatpour A; Faramarzi S; Geranpayeh L; Mirfakhraie R; Motevaseli E; Ghafouri-Fard S
Cancer Biomark; 2018; 22(1):49-54. PubMed ID: 29439313
[TBL] [Abstract][Full Text] [Related]
18. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
Tsutsumi Y
Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
[TBL] [Abstract][Full Text] [Related]
19. LncRNA-ATB promotes TGF-β-induced glioma cells invasion through NF-κB and P38/MAPK pathway.
Tang F; Wang H; Chen E; Bian E; Xu Y; Ji X; Yang Z; Hua X; Zhang Y; Zhao B
J Cell Physiol; 2019 Dec; 234(12):23302-23314. PubMed ID: 31140621
[TBL] [Abstract][Full Text] [Related]
20. Clinical values of two estrogen receptor signaling targeted lncRNAs in invasive ductal breast carcinoma.
Ilbeigi S; Naeimzadeh Y; Davoodabadi Farahani M; Rafi Monjezi M; Dastsooz H; Daraei A; Farahani F; Dastgheib A; Mansoori Y; Tabei SMB
Klin Onkol; 2021; 34(5):382-391. PubMed ID: 34702045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]